MFDS — authorised 15 October 2014
- Marketing authorisation holder: BOEHRINGER INGELHEIM
- Status: likely_approved
🇰🇷 Ofev in South Korea
MFDS authorised Ofev on 15 October 2014
Marketing authorisations
MFDS — authorised 2 April 2026
- Marketing authorisation holder: DEXCEL
- Status: likely_approved
Ofev in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Ofev approved in South Korea?
Yes. MFDS authorised it on 15 October 2014; MFDS authorised it on 2 April 2026.
Who is the marketing authorisation holder for Ofev in South Korea?
BOEHRINGER INGELHEIM holds the South Korean marketing authorisation.